Related News:
- FDA approves Roche’s Vabysmo, the first bispecific…
- FDA approves Roche’s Vabysmo, the first bispecific…
- CHMP recommends EU approval of Roche’s Vabysmo, the…
- New two-year data for Roche’s Vabysmo and Susvimo…
- New two-year data for Roche’s Vabysmo and Susvimo…
- European Commission approves Roche’s first-in-class…